A splice mutation in RASGRP2 gene in the patient with recurrent epistaxis and nasal vascular malformation

Zhong-Yu Shi Qing-Ling Lei Shao-Qin Duan Yan Zhou Ting-Ting Cui Yun-Bi Lin Chun-Hui Yang Chun-Yan Song Chun-Lian Fang Xin Tian Xian-Wen Zhang Ti-Long Huang 1 Department of Hematology,Kunming Children's Hospital,Kunming,China2 Medical Faculty,Kunming University of Science and Technology,Kunming,China
DOI: https://doi.org/10.1080/09537104.2024.2425664
2024-11-09
Platelets
Abstract:Platelet type bleeding disorder-18 (BDPLT18) caused by mutations of Ras guanyl releasing protein 2 ( RASGRP2 ) is a relatively rare, new autosomal recessive disorder. Here, we reported a splice mutation in RASGRP2 gene in the patient with recurrent epistaxis and nasal vascular malformation. The patient, an 8-year-old girl, suffered from anemia due to frequently severe recurrent epistaxis, requiring regular blood transfusions every 2–3 months. Hematological investigations showed moderate anemia (Hb: 89 g/L), normal platelet count, morphology, and platelet glycoproteins. Arachidonic acid and adenosine diphosphate induced platelet aggregation was markedly reduced in the patient. A homozygous splice variant (C.74–1 G>C) in RASGRP2 gene, located within the exon 3, was detected by next-generation sequencing. Interestingly, we identified nasal vascular malformation by percutaneous super-selective angiography during the treatment of an intractable epistaxis. Our case further support that genetic testing should be performed for some unexplained bleeding diseases. What is the context? What is new? What is the impact?
cell biology,hematology
What problem does this paper attempt to address?